BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:AZD1390 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of AZD1390\, from ClinicalTrials.gov estimat
 es.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06894979-2373@assetmemo.bio
DTSTAMP:20261121T004551Z
DTSTART;VALUE=DATE:20280331
DTEND;VALUE=DATE:20280401
SUMMARY:AZD1390: Phase 1 readout est. (NCT06894979)
DESCRIPTION:AZD1390\, phase 1\, Glioblastoma.\nStudy: Testing the Addition 
 of an Anti-Cancer Drug\, AZD1390\, During Radiation Therapy for Newly Diag
 nosed High Grade Glioma\, Diffuse Midline Glioma\, or Diffuse Intrinsic Po
 ntine Glioma\nEstimated primary completion: 31 March 2028. This is a Clini
 calTrials.gov estimate\, not a confirmed readout date\, and it can move.\n
 Drug page: https://assetmemo.bio/drug/azd1390#upcoming-events\nRegistry re
 cord: https://clinicaltrials.gov/study/NCT06894979
URL:https://assetmemo.bio/drug/azd1390#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07643870-2373@assetmemo.bio
DTSTAMP:20261121T004551Z
DTSTART;VALUE=DATE:20280412
DTEND;VALUE=DATE:20280413
SUMMARY:AZD1390: Phase 1 readout est. (NCT07643870)
DESCRIPTION:AZD1390\, phase 1.\nStudy: Human ADME Study of [14C]-AZD1390\nE
 stimated primary completion: 12 April 2028. This is a ClinicalTrials.gov e
 stimate\, not a confirmed readout date\, and it can move.\nDrug page: http
 s://assetmemo.bio/drug/azd1390#upcoming-events\nRegistry record: https://c
 linicaltrials.gov/study/NCT07643870
URL:https://assetmemo.bio/drug/azd1390#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT03970447-2373@assetmemo.bio
DTSTAMP:20261121T004551Z
DTSTART;VALUE=DATE:20280630
DTEND;VALUE=DATE:20280701
SUMMARY:AZD1390: Phase 2/3 readout est. (NCT03970447)
DESCRIPTION:AZD1390\, phase 2/3\, Glioblastoma.\nStudy: A Trial to Evaluate
  Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma\nEstimate
 d primary completion: June 2028. This is a ClinicalTrials.gov estimate\, n
 ot a confirmed readout date\, and it can move.\nDrug page: https://assetme
 mo.bio/drug/azd1390#upcoming-events\nRegistry record: https://clinicaltria
 ls.gov/study/NCT03970447
URL:https://assetmemo.bio/drug/azd1390#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
